{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:26:36Z","timestamp":1791293196819,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:00:00Z","timestamp":1453680000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:00:00Z","timestamp":1453680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Loss of MeCP2 (Methyl CpG binding protein 2) in Rett syndrome (RTT) causes brain weight decrease, shrinkage of the cortex with reduced dendritic arborization, behavioral abnormalities, seizures and cardio-respiratory complications. The observed monoamine neurotransmitters reduction in RTT suggested antidepressants as a possible therapy. We treated MeCP2-null mice from postnatal-day 28 for two weeks with desipramine, already tested in RTT, or mirtazapine, an antidepressant with limited side-effects, known to promote GABA release. Mirtazapine was more effective than desipramine in restoring somatosensory cortex thickness by fully rescuing pyramidal neurons dendritic arborization and spine density. Functionally, mirtazapine treatment normalized heart rate, breath rate, anxiety levels and eliminated the hopping behavior observed in MeCP2-null mice, leading to improved phenotypic score. These morphological and functional effects of mirtazapine were accompanied by reestablishment of the GABAergic and glutamatergic receptor activity recorded in cortex and brainstem tissues. Thus, mirtazapine can represent a new potential pharmacological treatment for the Rett syndrome.<\/jats:p>","DOI":"10.1038\/srep19796","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T07:06:22Z","timestamp":1453705582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Pharmacological treatment with mirtazapine rescues cortical atrophy and respiratory deficits in MeCP2 null mice"],"prefix":"10.1038","volume":"6","author":[{"given":"Tamara","family":"Bittolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo Antonio","family":"Raminelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Deiana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Baj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Vaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ferrazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Bernareggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Tongiorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,25]]},"reference":[{"key":"BFsrep19796_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/13810","volume":"23","author":"RE Amir","year":"1999","unstructured":"Amir, R. E. et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 23, 185\u2013188 (1999).","journal-title":"Nat Genet"},{"key":"BFsrep19796_CR2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.neuron.2007.10.001","volume":"56","author":"M Chahrour","year":"2007","unstructured":"Chahrour, M. & Zoghbi, H. Y. The story of Rett syndrome: from clinic to neurobiology. Neuron 56, 422\u2013437 (2007).","journal-title":"Neuron"},{"key":"BFsrep19796_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/cne.21673","volume":"508","author":"NP Belichenko","year":"2008","unstructured":"Belichenko, N. P., Belichenko, P. V., Li, H. H., Mobley, W. C. & Francke, U. Comparative study of brain morphology in Mecp2 mutant mouse models of Rett syndrome. J Comp Neurol 508, 184\u2013195 (2008).","journal-title":"J Comp Neurol"},{"key":"BFsrep19796_CR4","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/jnen\/64.6.537","volume":"64","author":"T Fukuda","year":"2005","unstructured":"Fukuda, T., Itoh, M., Ichikawa, T., Washiyama, K. & Goto, Y. Delayed maturation of neuronal architecture and synaptogenesis in cerebral cortex of Mecp2-deficient mice. J Neuropathol Exp Neurol 64, 537\u2013544 (2005).","journal-title":"J Neuropathol Exp Neurol"},{"key":"BFsrep19796_CR5","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1056\/NEJM198510103131504","volume":"313","author":"HY Zoghbi","year":"1985","unstructured":"Zoghbi, H. Y., Percy, A. K., Glaze, D. G., Butler, I. J. & Riccardi, V. M. Reduction of biogenic amine levels in the Rett syndrome. N Engl J Med 313, 921\u2013924 (1985).","journal-title":"N Engl J Med"},{"key":"BFsrep19796_CR6","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.neuroscience.2010.07.010","volume":"170","author":"M Santos","year":"2010","unstructured":"Santos, M. et al. Monoamine deficits in the brain of methyl-CpG binding protein 2 null mice suggest the involvement of the cerebral cortex in early stages of Rett syndrome. Neuroscience 170, 453\u2013467 (2010).","journal-title":"Neuroscience"},{"key":"BFsrep19796_CR7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nature09582","volume":"468","author":"HT Chao","year":"2010","unstructured":"Chao, H. T. et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 468, 263\u2013269 (2010).","journal-title":"Nature"},{"key":"BFsrep19796_CR8","doi-asserted-by":"crossref","unstructured":"Dani, V. S. et al. Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome. Proc Natl Acad Sci USA 102 (2005).","DOI":"10.1073\/pnas.0506071102"},{"key":"BFsrep19796_CR9","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1111\/j.1460-9568.2007.05466.x","volume":"25","author":"JC Roux","year":"2007","unstructured":"Roux, J. C., Dura, E., Moncla, A., Mancini, J. & Villard, L. Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome. Eur J Neurosci 25, 1915\u20131922 (2007).","journal-title":"Eur J Neurosci"},{"key":"BFsrep19796_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/01.chi.0000184931.26176.4a","volume":"45","author":"Y Amitai","year":"2006","unstructured":"Amitai, Y. & Frischer, H. Excess fatality from desipramine in children and adolescents. J Am Acad Child Adolesc Psychiatry 45, 54\u201360 (2006).","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BFsrep19796_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/00004583-199402000-00006","volume":"33","author":"BT Walsh","year":"1994","unstructured":"Walsh, B. T., Giardina, E. G., Sloan, R. P., Greenhill, L. & Goldfein, J. Effects of desipramine on autonomic control of the heart. J Am Acad Child Adolesc Psychiatry 33, 191\u2013197 (1994).","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BFsrep19796_CR12","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/S0140-6736(09)60046-5","volume":"373","author":"A Cipriani","year":"2009","unstructured":"Cipriani, A. et al. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 373, 746\u2013758 (2009).","journal-title":"Lancet"},{"key":"BFsrep19796_CR13","doi-asserted-by":"publisher","first-page":"34S","DOI":"10.1097\/00004714-199704001-00005","volume":"17","author":"GD Burrows","year":"1997","unstructured":"Burrows, G. D. & Kremer, C. M. Mirtazapine: clinical advantages in the treatment of depression. J Clin Psychopharmacol 17 Suppl 1, 34S\u201339S (1997).","journal-title":"J Clin Psychopharmacol"},{"key":"BFsrep19796_CR14","first-page":"159","volume":"59","author":"PM Hartmann","year":"1999","unstructured":"Hartmann, P. M. Mirtazapine: a newer antidepressant. Am Fam Physician 59, 159\u2013161 (1999).","journal-title":"Am Fam Physician"},{"key":"BFsrep19796_CR15","first-page":"131","volume":"9","author":"A Borkowska","year":"2007","unstructured":"Borkowska, A., Drozdz, W., Ziolkowska-Kochan, M. & Rybakowski, J. Enhancing effect of mirtazapine on cognitive functions associated with prefrontal cortex in patients with recurrent depression. Neuropsychopharmacol Hung 9, 131\u2013136 (2007).","journal-title":"Neuropsychopharmacol Hung"},{"key":"BFsrep19796_CR16","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.pnpbp.2011.03.004","volume":"35","author":"JH Stenberg","year":"2011","unstructured":"Stenberg, J. H. et al. More evidence on proneurocognitive effects of add-on mirtazapine in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 35, 1080\u20131086 (2011).","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFsrep19796_CR17","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1038\/sj.mp.4001021","volume":"7","author":"JH Krystal","year":"2002","unstructured":"Krystal, J. H. et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psychiatry 7 Suppl 1, S71\u201380 (2002).","journal-title":"Mol Psychiatry"},{"key":"BFsrep19796_CR18","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/85899","volume":"27","author":"J Guy","year":"2001","unstructured":"Guy, J., Hendrich, B., Holmes, M., Martin, J. E. & Bird, A. A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat Genet 27, 322\u2013326 (2001).","journal-title":"Nat Genet"},{"key":"BFsrep19796_CR19","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1242\/dmm.011007","volume":"5","author":"DM Katz","year":"2012","unstructured":"Katz, D. M. et al. Preclinical research in Rett syndrome: setting the foundation for translational success. Dis Model Mech 5, 733\u2013745 (2012).","journal-title":"Dis Model Mech"},{"key":"BFsrep19796_CR20","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.mcn.2004.07.006","volume":"27","author":"N Kishi","year":"2004","unstructured":"Kishi, N. & Macklis, J. D. MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 27, 306\u2013321 (2004).","journal-title":"Mol Cell Neurosci"},{"key":"BFsrep19796_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/nedt.1.1.59.52296","volume":"1","author":"F Lavergne","year":"2005","unstructured":"Lavergne, F., Berlin, I., Gamma, A., Stassen, H. & Angst, J. Onset of improvement and response to mirtazapine in depression: a multicenter naturalistic study of 4771 patients. Neuropsychiatr Dis Treat 1, 59\u201368 (2005).","journal-title":"Neuropsychiatr Dis Treat"},{"key":"BFsrep19796_CR22","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/npp.2012.5","volume":"37","author":"G Baj","year":"2012","unstructured":"Baj, G. et al. Physical exercise and antidepressants enhance BDNF targeting in hippocampal CA3 dendrites: further evidence of a spatial code for BDNF splice variants. Neuropsychopharmacology 37, 1600\u20131611 (2012).","journal-title":"Neuropsychopharmacology"},{"key":"BFsrep19796_CR23","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.pediatrneurol.2007.06.009","volume":"37","author":"M Rohdin","year":"2007","unstructured":"Rohdin, M. et al. Disturbances in cardiorespiratory function during day and night in Rett syndrome. Pediatr Neurol 37, 338\u2013344 (2007).","journal-title":"Pediatr Neurol"},{"key":"BFsrep19796_CR24","doi-asserted-by":"publisher","first-page":"9941","DOI":"10.1073\/pnas.1311685111","volume":"111","author":"J Castro","year":"2014","unstructured":"Castro, J. et al. Functional recovery with recombinant human IGF1 treatment in a mouse model of Rett Syndrome. Proc Natl Acad Sci USA 111, 9941\u20139946 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep19796_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/nprot.2007.44","volume":"2","author":"AA Walf","year":"2007","unstructured":"Walf, A. A. & Frye, C. A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat Protoc 2, 322\u2013328 (2007).","journal-title":"Nat Protoc"},{"key":"BFsrep19796_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/hmg\/ddi045","volume":"14","author":"RC Samaco","year":"2005","unstructured":"Samaco, R. C., Hogart, A. & LaSalle, J. M. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet 14, 483\u2013492 (2005).","journal-title":"Hum Mol Genet"},{"key":"BFsrep19796_CR27","doi-asserted-by":"publisher","first-page":"2470","DOI":"10.1152\/jn.00601.2009","volume":"103","author":"ZW Zhang","year":"2010","unstructured":"Zhang, Z. W., Zak, J. D. & Liu, H. MeCP2 is required for normal development of GABAergic circuits in the thalamus. J Neurophysiol 103, 2470\u20132481 (2010).","journal-title":"J Neurophysiol"},{"key":"BFsrep19796_CR28","doi-asserted-by":"publisher","first-page":"13238","DOI":"10.1073\/pnas.192445299","volume":"99","author":"R Miledi","year":"2002","unstructured":"Miledi, R., Eusebi, F., Martinez-Torres, A., Palma, E. & Trettel, F. Expression of functional neurotransmitter receptors in Xenopus oocytes after injection of human brain membranes. Proc Natl Acad Sci USA 99, 13238\u201313242 (2002).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep19796_CR29","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1073\/pnas.0611513104","volume":"104","author":"A Bernareggi","year":"2007","unstructured":"Bernareggi, A., Duenas, Z., Reyes-Ruiz, J. M., Ruzzier, F. & Miledi, R. Properties of glutamate receptors of Alzheimer's disease brain transplanted to frog oocytes. Proc Natl Acad Sci USA 104, 2956\u20132960 (2007).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep19796_CR30","doi-asserted-by":"publisher","first-page":"3904","DOI":"10.1523\/JNEUROSCI.13-09-03904.1993","volume":"13","author":"KA Yamada","year":"1993","unstructured":"Yamada, K. A. & Tang, C. M. Benzothiadiazides inhibit rapid glutamate receptor desensitization and enhance glutamatergic synaptic currents. J Neurosci 13, 3904\u20133915 (1993).","journal-title":"J Neurosci"},{"key":"BFsrep19796_CR31","doi-asserted-by":"publisher","first-page":"10973","DOI":"10.1073\/pnas.0804386105","volume":"105","author":"A Limon","year":"2008","unstructured":"Limon, A., Reyes-Ruiz, J. M. & Miledi, R. Microtransplantation of neurotransmitter receptors from postmortem autistic brains to Xenopus oocytes. Proc Natl Acad Sci USA 105, 10973\u201310977 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep19796_CR32","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1126\/science.6164095","volume":"211","author":"T Mohandas","year":"1981","unstructured":"Mohandas, T., Sparkes, R. S. & Shapiro, L. J. Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science 211, 393\u2013396 (1981).","journal-title":"Science"},{"key":"BFsrep19796_CR33","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1138389","volume":"315","author":"J Guy","year":"2007","unstructured":"Guy, J., Gan, J., Selfridge, J., Cobb, S. & Bird, A. Reversal of neurological defects in a mouse model of Rett syndrome. Science 315, 1143\u20131147 (2007).","journal-title":"Science"},{"key":"BFsrep19796_CR34","first-page":"423","volume":"33","author":"T Frodl","year":"2008","unstructured":"Frodl, T. et al. Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci 33, 423\u2013430 (2008).","journal-title":"J Psychiatry Neurosci"},{"key":"BFsrep19796_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s004010050582","volume":"93","author":"PV Belichenko","year":"1997","unstructured":"Belichenko, P. V., Hagberg, B. & Dahlstrom, A. Morphological study of neocortical areas in Rett syndrome. Acta Neuropathol 93, 50\u201361 (1997).","journal-title":"Acta Neuropathol"},{"key":"BFsrep19796_CR36","first-page":"213","volume":"13","author":"B Ruszczycki","year":"2012","unstructured":"Ruszczycki, B. et al. Sampling issues in quantitative analysis of dendritic spines morphology. BMC Bioinformatics 13, 213 (2012).","journal-title":"Bioinformatics"},{"key":"BFsrep19796_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuroscience.2004.06.072","volume":"129","author":"P Zhong","year":"2004","unstructured":"Zhong, P. & Yan, Z. Chronic antidepressant treatment alters serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons. Neuroscience 129, 65\u201373 (2004).","journal-title":"Neuroscience"},{"key":"BFsrep19796_CR38","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1136\/jnnp.2004.037010","volume":"76","author":"A Munchau","year":"2005","unstructured":"Munchau, A. et al. Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression. J Neurol Neurosurg Psychiatry 76, 527\u2013533 (2005).","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFsrep19796_CR39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neuron.2007.08.018","volume":"56","author":"HT Chao","year":"2007","unstructured":"Chao, H. T., Zoghbi, H. Y. & Rosenmund, C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron 56, 58\u201365 (2007).","journal-title":"Neuron"},{"key":"BFsrep19796_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1006\/exnr.1999.7030","volume":"156","author":"ME Blue","year":"1999","unstructured":"Blue, M. E., Naidu, S. & Johnston, M. V. Altered development of glutamate and GABA receptors in the basal ganglia of girls with Rett syndrome. Exp Neurol 156, 345\u2013352 (1999).","journal-title":"Exp Neurol"},{"key":"BFsrep19796_CR41","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1177\/08830738050200091101","volume":"20","author":"MV Johnston","year":"2005","unstructured":"Johnston, M. V., Blue, M. E. & Naidu, S. Rett syndrome and neuronal development. J Child Neurol 20, 759\u2013763 (2005).","journal-title":"J Child Neurol"},{"key":"BFsrep19796_CR42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.neulet.2010.08.001","volume":"483","author":"WH Roden","year":"2010","unstructured":"Roden, W. H., Peugh, L. D. & Jansen, L. A. Altered GABA(A) receptor subunit expression and pharmacology in human Angelman syndrome cortex. Neurosci Lett 483, 167\u2013172 (2010).","journal-title":"Neurosci Lett"},{"key":"BFsrep19796_CR43","doi-asserted-by":"publisher","first-page":"11521","DOI":"10.1523\/JNEUROSCI.4373-05.2005","volume":"25","author":"JC Viemari","year":"2005","unstructured":"Viemari, J. C. et al. Mecp2 deficiency disrupts norepinephrine and respiratory systems in mice. J Neurosci 25, 11521\u201311530 (2005).","journal-title":"J Neurosci"},{"key":"BFsrep19796_CR44","first-page":"661","volume":"56","author":"Z Rogoz","year":"2005","unstructured":"Rogoz, Z., Skuza, G. & Legutko, B. Repeated treatment with mirtazepine induces brain-derived neurotrophic factor gene expression in rats. J Physiol Pharmacol 56, 661\u2013671 (2005).","journal-title":"J Physiol Pharmacol"},{"key":"BFsrep19796_CR45","first-page":"19","volume":"57","author":"T de Boer","year":"1996","unstructured":"de Boer, T. The pharmacologic profile of mirtazapine. J Clin Psychiatry 57 Suppl 4, 19\u201325 (1996).","journal-title":"J Clin Psychiatry"},{"key":"BFsrep19796_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00210-010-0583-9","volume":"383","author":"I Staudacher","year":"2011","unstructured":"Staudacher, I. et al. hERG K+ channel-associated cardiac effects of the antidepressant drug desipramine. Naunyn Schmiedebergs Arch Pharmacol 383, 119\u2013139 (2011).","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BFsrep19796_CR47","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","volume":"7","author":"SA Anttila","year":"2001","unstructured":"Anttila, S. A. & Leinonen, E. V. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev 7, 249\u2013264 (2001).","journal-title":"CNS Drug Rev"},{"key":"BFsrep19796_CR48","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1152\/jn.00826.2007","volume":"99","author":"L Medrihan","year":"2008","unstructured":"Medrihan, L. et al. Early defects of GABAergic synapses in the brain stem of a MeCP2 mouse model of Rett syndrome. J Neurophysiol 99, 112\u2013121 (2008).","journal-title":"J Neurophysiol"},{"key":"BFsrep19796_CR49","doi-asserted-by":"publisher","first-page":"18208","DOI":"10.1073\/pnas.1012104107","volume":"107","author":"AP Abdala","year":"2010","unstructured":"Abdala, A. P., Dutschmann, M., Bissonnette, J. M. & Paton, J. F. Correction of respiratory disorders in a mouse model of Rett syndrome. Proc Natl Acad Sci USA 107, 18208\u201318213 (2010).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep19796_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.resp.2009.04.017","volume":"168","author":"DM Katz","year":"2009","unstructured":"Katz, D. M., Dutschmann, M., Ramirez, J. M. & Hilaire, G. Breathing disorders in Rett syndrome: progressive neurochemical dysfunction in the respiratory network after birth. Respir Physiol Neurobiol 168, 101\u2013108 (2009).","journal-title":"Respir Physiol Neurobiol"},{"key":"BFsrep19796_CR51","first-page":"105","volume":"53","author":"Z Rogoz","year":"2002","unstructured":"Rogoz, Z., Wrobel, A., Dlaboga, D., Maj, J. & Dziedzicka-Wasylewska, M. Effect of repeated treatment with mirtazapine on the central alpha1-adrenergic receptors. J Physiol Pharmacol 53, 105\u2013116 (2002).","journal-title":"J Physiol Pharmacol"},{"key":"BFsrep19796_CR52","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/7854_2012_226","volume":"14","author":"MM Lee","year":"2013","unstructured":"Lee, M. M., Reif, A. & Schmitt, A. G. Major depression: a role for hippocampal neurogenesis? Curr Top Behav Neurosci 14, 153\u2013179 (2013).","journal-title":"Curr Top Behav Neurosci"},{"key":"BFsrep19796_CR53","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejphar.2004.01.018","volume":"487","author":"P Devoto","year":"2004","unstructured":"Devoto, P., Flore, G., Pira, L., Longu, G. & Gessa, G. L. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex. Eur J Pharmacol 487, 105\u2013111 (2004).","journal-title":"Eur J Pharmacol"},{"key":"BFsrep19796_CR54","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1093\/hmg\/ddu008","volume":"23","author":"EC Williams","year":"2014","unstructured":"Williams, E. C. et al. Mutant astrocytes differentiated from Rett syndrome patients-specific iPSCs have adverse effects on wild-type neurons. Hum Mol Genet 23, 2968\u20132980 (2014).","journal-title":"Hum Mol Genet"},{"key":"BFsrep19796_CR55","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1258\/ebm.2010.010261","volume":"236","author":"G Calfa","year":"2011","unstructured":"Calfa, G., Percy, A. K. & Pozzo-Miller, L. Experimental models of Rett syndrome based on Mecp2 dysfunction. Exp Biol Med (Maywood) 236, 3\u201319 (2011).","journal-title":"Exp Biol Med (Maywood)"},{"key":"BFsrep19796_CR56","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature11556","volume":"490","author":"SC Landis","year":"2012","unstructured":"Landis, S. C. et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490, 187\u2013191 (2012).","journal-title":"Nature"},{"key":"BFsrep19796_CR57","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fneur.2010.00157","volume":"1","author":"A Ranjan","year":"2010","unstructured":"Ranjan, A. & Mallick, B. N. A modified method for consistent and reliable Golgi-cox staining in significantly reduced time. Front Neurol 1, 157 (2010).","journal-title":"Front Neurol"},{"key":"BFsrep19796_CR58","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1523\/JNEUROSCI.12-07-02685.1992","volume":"12","author":"KM Harris","year":"1992","unstructured":"Harris, K. M., Jensen, F. E. & Tsao, B. Three-dimensional structure of dendritic spines and synapses in rat hippocampus (CA1) at postnatal day 15 and adult ages: implications for the maturation of synaptic physiology and long-term potentiation. J Neurosci 12, 2685\u20132705 (1992).","journal-title":"J Neurosci"},{"key":"BFsrep19796_CR59","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/978-1-59745-000-3_24","volume":"322","author":"R Miledi","year":"2006","unstructured":"Miledi, R., Palma, E. & Eusebi, F. Microtransplantation of neurotransmitter receptors from cells to Xenopus oocyte membranes: new procedure for ion channel studies. Methods Mol Biol 322, 347\u2013355 (2006).","journal-title":"Methods Mol Biol"},{"key":"BFsrep19796_CR60","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1098\/rspb.1982.0089","volume":"216","author":"R Miledi","year":"1982","unstructured":"Miledi, R., Parker, I. & Sumikawa, K. Synthesis of chick brain GABA receptors by frog oocytes. Proc R Soc Lond B Biol Sci 216, 509\u2013515 (1982).","journal-title":"Proc R Soc Lond B Biol Sci"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep19796","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep19796.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep19796.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T08:49:46Z","timestamp":1672822186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep19796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,25]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,22]]}},"alternative-id":["BFsrep19796"],"URL":"https:\/\/doi.org\/10.1038\/srep19796","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,25]]},"assertion":[{"value":"6 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19796"}}